BEIRA advises on a USD 485 m sale of the biotech firm Dutalys to Roche

<< Back

BEIRA served as lead counsel to all sellers of biotechnology company Dutalys to life science group Roche. Dutalys specializes in the discovery and development of fully human, bi-specific antibodies based on their proprietary DutaMabs (tm) technology.

more73.43 KB